Clinical Data Presented at 2022 North American Neuromodulation Society (NANS) Annual Meeting Reinforce Significant and Durable Benefits of Nevro's 10 kHz Therapy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Related Keywords

California ,United States ,Idaho ,Redwood City ,Erika Petersen ,Julie Dewey ,D Keith Grossman ,Jessica Jameson ,Leonardo Kapural ,Instagram ,Linkedin ,Twitter ,Axis Spine Center ,American Neuromodulation Society ,Nevro Corp ,Exchange Commission ,Us Food Drug Administration ,Facebook ,Corp Communications ,University Of Arkansas ,Annual Meeting ,Diabetic Neuropathy ,Surgical Refractory Back Pain ,Principal Investigators ,Painful Diabetic Neuropathy ,Principal Investigator ,Restorative Neurosurgery ,Medical Sciences ,Treating Non Surgical Refractory Back Pain ,Conventional Medical Management ,P Value Cost Effectiveness ,Non Surgical Refractory Back Pain ,Premarket Approval ,Senza Omnia ,Month Multicenter Randomized Controlled Trial ,North American Neuromodulation Society ,Treating Non Surgical Refractory Back ,Non Surgical Refractory Back ,Private Securities Litigation Reform Act ,Quarterly Report ,Investor Relations ,